Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Thromb Res. 2012 May;129(5):611-5. doi: 10.1016/j.thromres.2011.11.007. Epub 2011 Nov 30.
Puumala virus (PUUV) infection is a viral hemorrhagic fever with renal syndrome (HFRS) characterized by thrombocytopenia and acute impairment of renal function. We aimed to assess whether genetic polymorphisms of platelet antigens together with those of von Willebrand factor (VWF) and plasminogen activator inhibitor (PAI-1) correlate with disease severity. Patients and methods 172 consecutive hospital-treated patients with serologically confirmed acute PUUV infection were included. Platelet glycoprotein (GP) IIIa T>C (rs5918), GP Ia T>C (rs1126643), GP Ib C>T (rs6065), GP VI T>C (rs1613662), VWF A>G (rs1063856) and PAI-1 A>G (rs2227631) were genotyped. The associations of the rarer alleles with variables reflecting the severity of the disease were analyzed.
PAI-1G-carriers had higher maximum creatinine level compared with the non-carriers (median 213 μmol/l, range 60-1499 μmol/l vs. median 122 μmol/l, range 51-1156 μmol/l, p = 0.01). The GG-genotypes had higher creatinine levels than GA- and AA-genotypes (medians 249 μmol/l, 204 μmol/l and 122 μmol/l, respectively, p = 0.03). Polymorphisms of GP VI and VWF associated with lower creatinine levels during PUUV infection. The minor C-allele of GP Ia associated with lower platelet counts (median 44 × 10(9)/l, range 20-90 × 10(9)/l vs median 64 × 10(9)/l, range 3-238 × 10(9)/l; p = 0.02).
Polymorphism of PAI-1, a major regulator of fibrinolysis, has an adverse impact on the outcome of kidney function in PUUV-HFRS. Platelet collagen receptor GP Ia polymorphism associates with lower platelet count.
普马拉病毒(PUUV)感染是一种病毒性出血热伴肾综合征(HFRS),其特征为血小板减少和急性肾功能损害。我们旨在评估血小板抗原的遗传多态性与血管性血友病因子(VWF)和纤溶酶原激活物抑制剂(PAI-1)的遗传多态性是否与疾病严重程度相关。
共纳入 172 例经血清学证实的急性 PUUV 感染住院治疗的连续患者。对血小板糖蛋白(GP)IIIa T>C(rs5918)、GP Ia T>C(rs1126643)、GP Ib C>T(rs6065)、GP VI T>C(rs1613662)、VWF A>G(rs1063856)和 PAI-1 A>G(rs2227631)进行基因分型。分析了罕见等位基因与反映疾病严重程度的变量之间的关联。
与非携带者相比,PAI-1G 携带者的最大肌酐水平更高(中位数 213μmol/l,范围 60-1499μmol/l 与中位数 122μmol/l,范围 51-1156μmol/l,p=0.01)。GG 基因型的肌酐水平高于 GA 和 AA 基因型(中位数分别为 249μmol/l、204μmol/l 和 122μmol/l,p=0.03)。GP VI 和 VWF 的多态性与 PUUV 感染期间的肌酐水平降低相关。GP Ia 的次要 C 等位基因与血小板计数降低相关(中位数 44×10(9)/l,范围 20-90×10(9)/l 与中位数 64×10(9)/l,范围 3-238×10(9)/l;p=0.02)。
纤溶酶原主要调节因子 PAI-1 的多态性对 PUUV-HFRS 肾功能的结果有不利影响。血小板胶原受体 GP Ia 多态性与血小板计数降低有关。